Regorafenib
【Molecular composition】:
【CAS NO】:755037-03-7
【source】:Regorafenib
【authentication】:
【specifications】:In-House
【DMF】:—
【use to】:
Oncology API.
Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy